Bharat Biotech

New Delhi: Bharat Biotech’s Covaxin is 77.8 per cent effective in the Phase III trials against the novel coronavirus, according to The Drug Controller General of India (DCGI). The Drug Controller General of India (DCGI) held a review…

New Delhi: Amid concerns over the effectiveness of Covid vaccines, the Hyderabad-based Bharat Biotech has submitted phase III trial data of Covaxin to Drugs Controller General of India (DCGI). Phase-III trial data is also required for…

Hyderabad: Bharat Biotech may commence pediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The vaccine maker has already received permission to carry out trials on children aged 2-18 years.…

New-Delhi: The Drug Controller General of India (DGCI) on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children belonging to the age group of 2 to 18 years. Bharat Biotech will…

New Delhi:There is no stock of  Covaxin for those between 18-45 of age and around 100 newly setup vaccination centers at government schools will administer Covishield only. The Kejriwal administration said, as of now, there is no idea…

New Delhi: Bharat Biotech's Covid-19 vaccine Covaxin got approved by an expert panel on Tuesday for phase II and III human clinical trials on those between 2-18 years of age. The Subject Expert Committee (SEC) on Covid-19 of the Central…

Hyderabad: Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states. The states are Andhra Pradesh, Assam, Chhattisgarh, Delhi, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Odisha,…

New Delhi: The Indian biotechnology company Bharat Biotech has started its direct supply of Covid-19 vaccine ‘Covaxin’ to 14 states from May 1, according to the company's co-founder and Joint Managing Director Suchitra Ella. The supply…

New-Delhi: Bharat Biotech, the manufacturer of Covaxin has released an advisory asking who are immuno-compromised or on medication that affect the immune system, not to take the vaccine shot against the novel coronavirus. The company…

New Delhi: The Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use, paving the way for their roll-out and administration to…